i-Base home
Search Menu
  • Home
  • HTB
  • 2019
  • December

HTB

December 2019

Contents

Editorial

  • i-Base 2019 appeal: we need your help….
  • HTB 13 December 2019 online

Supplements

  • Introduction to ART – October 2019
  • UK Guide to PrEP – November 2019

Conference reports

  • 17th European AIDS Conference (EACS 2019)
  • Capsid inhibitor GS-6207 (lenacapavir): potential for 6 monthly dosing for MDR HIV
  • Dolutegravir/lamivudine as dual ART
  • Weight changes with doravirine-based first line therapy
  • Bone and renal changes in the ADVANCE trial
  • 10th International Workshop on HIV and Ageing
  • Impact of isolation and loneliness on older people living with HIV

Antiretrovirals

  • Doravirine approved by NHS England as single NNRTI and as part of FDC with 3TC/TDF
  • Fostemsavir submitted to US FDA for multidrug resistant HIV
  • Paediatric dispersible formulation of dolutegravir submitted to EMA and FDA

Lipodystrophy and metabolic complications

  • Tesamorelin for NAFLD in people living with HIV

PDFs

  • 13 December 2019 vol 20 no 14
  • HTB RSS

Early access

  • US FDA approves long-acting injectable HIV treatment: monthly dosing 22 January 2021
  • Latest update on HIV and COVID-19 from BHIVA and EACS (January 2021) 15 January 2021
  • Baseline NNRTI resistance linked to poorer response to first-line dolutegravir in the ADVANCE study       14 January 2021
  • Monoclonal antibody bamlanivimab is not effective in advanced COVID-19: lack of early signal stops study early 10 January 2021
  • All early access reports

Current issues

  • January 2021
  • December 2020
  • November 2020
  • Back issues

Special report

  • Early results report 90% efficacy with from Pfizer/BioNTech COVID vaccine 11 November 2020

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook